arrow
A

Angioletta Lasagna

Fondazione IRCCS Policlinico San Matteo
H指数:17
被引数:744

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Visceral-to-subcutaneous fat ratio is a time-stable predictor of survival and toxicity in advanced hepatocellular carcinoma

内脏-皮下脂肪比是晚期肝细胞癌患者生存和毒性的时稳预测因子

2026-08-050
OAAI
Trastuzumab–Deruxtecan for the Treatment of Metastatic Breast Cancer Patients: Data from Real World Studies

Quaquarini E,Luelli F,Lasagna A,Rizzo G,Perrone L,Figini S,等. 曲妥珠单抗德鲁替康用于治疗转移性乳腺癌患者:真实世界研究数据. Cancers (Basel). (2025) 17:3505. doi: 10.3390/cancers17213505

Cancers
IF4.4
2026-03-030
OAAI
Adjuvant abemaciclib in early-stage breast cancer: hypothesis-generating safety observations from a real-world cohort study

新辅助阿贝西利(abemaciclib)在早期乳腺癌中的应用:一项真实世界队列研究的假设生成性安全性观察

2025-12-110
PRE
Case Report: Epstein-Barr virus negative lymphoepithelioma-like cholangiocarcinoma: a rare tumor that deserves further exploration. Report of a case with distinct genomic and clinical features

病例报告:EB病毒阴性淋巴上皮瘤样胆管癌:一种值得进一步探索的罕见肿瘤。具有独特基因组学和临床特征的病例报告。

2025-08-050
OA
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies

实体肿瘤和糖尿病患者疫苗接种:现有证据与建议。一份来自多学科科学学会专家组的立场声明

2025-04-230
OA
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium
2024-07-010
OAAI
Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature
2023-02-219
OAAI
The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study
2022-11-268
OAAI